{"status": "ok", "totalResults": 547, "articles": [{"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Greenply Industries; target of Rs 237: YES Securities", "description": "YES Securities is bullish on Greenply Industries has recommended buy rating on the stock with a target price of Rs 237 in its research report date May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-greenply-industries-target-of-rs-237-yes-securities-8522161.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T14:37:31Z", "content": "YES Securities' research report on Greenply Industries\r\nGreenply Industries Ltd (GIL) registered a decent set of numbers for Q4FY22. Topline grew by 13%YoY (4% above our estimates), however EBITDA ma\u2026 [+1934 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Triveni Turbine; target of Rs 273: YES Securities", "description": "YES Securities is bullish on Triveni Turbine has recommended buy rating on the stock with a target price of Rs 273 in its research report date May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-triveni-turbine-target-of-rs-273-yes-securities-8522121.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T14:36:05Z", "content": "YES Securities' research report on Triveni Turbine\r\nTriveni Turbine (TRIV) reported healthy performance on account of better sales mix and execution ramp up. EBITDA Margins expanded ~390bps YoY despi\u2026 [+1683 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Bharat Forge; target of Rs 865: Motilal Oswal", "description": "Motilal Oswal is bullish on Bharat Forge recommended buy rating on the stock with a target price of Rs 865 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-bharat-forge-target-of-rs-865-motilal-oswal-8522181.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_3-1-770x433.jpg", "publishedAt": "2022-05-17T14:29:11Z", "content": "Motilal Oswal's research report on Bharat Forge\r\nBharat Forge (BHFC)s 4QFY22 result was above expectation propelled by strong all-round performance with better-than-expected revenue, margins and PAT.\u2026 [+1083 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Vinati Organics; target of Rs 2379: Motilal Oswal", "description": "Motilal Oswal is bullish on Vinati Organics recommended buy rating on the stock with a target price of Rs 2379 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-vinati-organics-target-of-rs-2379-motilal-oswal-8522211.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/01/Buy-770x433.png", "publishedAt": "2022-05-17T14:29:09Z", "content": "Motilal Oswal's research report on Vinati Organics\r\nVO reported a beat on our EBITDA estimate, with gross margin in line at 46% (-300bp QoQ). Revenue was above our estimate in 4QFY22, with EBITDAM at\u2026 [+1505 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Eris Lifesciences; target of Rs 870: Motilal Oswal", "description": "Motilal Oswal is bullish on Eris Lifesciences recommended buy rating on the stock with a target price of Rs 870 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-eris-lifesciences-target-of-rs-870-motilal-oswal-3-8522221.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T14:29:08Z", "content": "Motilal Oswal's research report on Eris Lifesciences\r\nThe Dydrogesterone market is at an interesting phase, with an improvement in demand due to better access, affordability, and technical superiorit\u2026 [+1480 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Neutral GSK Pharma; target of Rs 1570: Motilal Oswal", "description": "Motilal Oswal recommended Neutral rating on GSK Pharma with a target price of Rs 1570 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/neutral-gsk-pharma-target-of-rs-1570-motilal-oswal-8522251.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/10/neutral3-770x433.jpg", "publishedAt": "2022-05-17T14:29:06Z", "content": "Motilal Oswal's research report on GSK Pharma\r\nGLXO delivered a lower-than-expected performance in 4QFY22. Subdued YoY growth in sales and higher raw material cost affected profitability. We lower ou\u2026 [+868 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Bharat Forge; target of Rs 810: Emkay Global Financial", "description": "Emkay Global Financial is bullish on Bharat Forge has recommended buy rating on the stock with a target price of Rs 810 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-bharat-forge-target-of-rs-810-emkay-global-financial-8522371.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T14:19:37Z", "content": "Emkay Global Financial's report on Bharat Forge\r\nBHFC's Q4 EBITDA grew 29% yoy to Rs4.3bn and came in 15% above our estimate, driven by better scale. Revenue grew by 28% yoy to Rs16.7bn, 12% above es\u2026 [+1506 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Kalpataru Power; target of Rs 500: Emkay Global Financial", "description": "Emkay Global Financial is bullish on Kalpataru Power has recommended buy rating on the stock with a target price of Rs 500 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-kalpataru-power-target-of-rs-500-emkay-global-financial-8522441.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-05-17T14:19:25Z", "content": "Emkay Global Financial's report on Kalpataru Power\r\nKPTL (Standalone) reported a 14% YoY decline in revenue in Q4FY22 and a ~200bps correction in EBITDAM, due to lower dispatch in T&amp;D, weak inflo\u2026 [+1236 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Balkrishna Industries: target of Rs 2450: Sharekhan", "description": "Sharekhan is bullish on Balkrishna Industries has recommended buy rating on the stock with a target price of Rs 2450 in its research report dated May 13, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-balkrishna-industries-target-of-rs-2450-sharekhan-8522741.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-1-770x433.jpg", "publishedAt": "2022-05-17T14:08:54Z", "content": "Sharekhan's research report on Balkrishna Industries\r\nThe stock trades at P/E multiple of 17.7x and EV/EBITDA multiple of 12.9x its FY2024E estimates. For Q4FY22, Balkrishnas results were results ahe\u2026 [+1060 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Bank of Baroda: target of Rs 128: Sharekhan", "description": "Sharekhan is bullish on Bank of Baroda has recommended buy rating on the stock with a target price of Rs 128 in its research report dated May 13, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-bank-of-baroda-target-of-rs-128-sharekhan-2-8522751.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-05-17T14:08:51Z", "content": "Sharekhan's research report on Bank of Baroda\r\nBOB reported healthy loan growth of 10% y-o-y/6% q-o-q versus 4% y-o-y in the past quarter, led by strong growth in retail (17% y-o-y), agri book (10% y\u2026 [+932 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Tech Mahindra: target of Rs 1650: Sharekhan", "description": "Sharekhan is bullish on Tech Mahindra has recommended buy rating on the stock with a target price of Rs 1650 in its research report dated May 13, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-tech-mahindra-target-of-rs-1650-sharekhan-2-8522791.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T14:08:48Z", "content": "Sharekhan's research report on Tech Mahindra\r\nQ4FY22 revenues were in-line, but EBIT margin lagged our estimates; Q4 saw strong deal intake, healthy deal pipeline, good client mining and logo additio\u2026 [+1177 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Titan Company: target of Rs 2900: Sharekhan", "description": "Sharekhan is bullish on Titan Company has recommended buy rating on the stock with a target price of Rs 2900 in its research report dated May 13, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-titan-company-target-of-rs-2900-sharekhan-5-8522801.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/buy-2-1-770x433.jpg", "publishedAt": "2022-05-17T14:08:46Z", "content": "\"Indias specialty chemicals industry is a\u00a0decadal growth opportunity and it is still not too late to participate in the value\u00a0creation process. We prefer CRAMS/CSM players Navin Fluorine (Navin) and \u2026 [+1715 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy State Bank of India: target of Rs 600: Sharekhan", "description": "Sharekhan is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 600 in its research report dated May 13, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-state-bank-of-india-target-of-rs-600-sharekhan-8522811.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T14:08:43Z", "content": "Sharekhan's research report on State Bank of India\r\nSBI reported strong loan growth of 12% y-o-y/ 6% q-o-q above estimates (of 9% y-o-y) led by strong growth in mortgages (11.5% y-o-y) , wholesale bo\u2026 [+1207 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Gujarat Fluorochemicals; target of Rs 3215: KR Choksey", "description": "KR Choksey is bullish on Gujarat Fluorochemicals has recommended buy rating on the stock with a target price of Rs 3215 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-gujarat-fluorochemicals-target-of-rs-3215-kr-choksey-8522951.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_3-1-770x433.jpg", "publishedAt": "2022-05-17T13:57:54Z", "content": "KR Choksey's research report on Gujarat Fluorochemicals\r\nDuring the quarter GFLs revenue came at INR 10,738 Mn (+27.78% YoY / +6.87% QoQ). The growth was mainly led by robust demand for its fluoropol\u2026 [+1182 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy Tech Mahindra; target of Rs 1447: KR Choksey", "description": "KR Choksey is bullish on Tech Mahindra has recommended buy rating on the stock with a target price of Rs 1447 in its research report dated May 16, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/buy-tech-mahindra-target-of-rs-1447-kr-choksey-8522971.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_4-770x433.jpg", "publishedAt": "2022-05-17T13:57:41Z", "content": "KR Choksey's research report on Tech Mahindra\r\nTech Mahindra Ltd (TECHM) Q4FY22 performance was marginally higher than with our estimate. Dollar Revenue was up 4.9% QoQ and in CC term grew by 5.4% Qo\u2026 [+2066 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Buy State Bank of India; target of Rs 617: KR Choksey", "description": "KR Choksey is bullish on State Bank of India has recommended buy rating on the stock with a target price of Rs 617 in its research report dated May 17, 2022.", "url": "https://www.moneycontrol.com/news/business/buy-state-bank-of-india-target-of-rs-617-kr-choksey-8523011.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/11/Buy_1-770x433.jpg", "publishedAt": "2022-05-17T13:57:29Z", "content": "KR Choksey's research report on State Bank of India\r\nNet Interest Income (NII) for Q4FY22 increased by 15.3% YoY (+1.7% QoQ) at INR 3,11,979 Mn. NIMs stood at 3.4% in Q4FY22 vs 3.11% in Q4FY21. The N\u2026 [+1407 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Accumulate Bandhan Bank; target of Rs 385: KR Choksey", "description": "KR Choksey recommended\u00c2\u00a0accumulate rating on Bandhan Bank with a target price of Rs 385 in its research report dated May 17, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/accumulate-bandhan-bank-target-of-rs-385-kr-choksey-8523021.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/06/accumulate2-770x433.jpg", "publishedAt": "2022-05-17T13:57:18Z", "content": "KR Choksey's research report on Bandhan Bank\r\nNet Interest income reported at INR 25,398Mn (+44.6% yoy / +19.5% qoq) and NIM improved at 8.7% in Q4FY22 as against 6.8% in Q4FY21. Non-Interest Income \u2026 [+1510 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Broker Research", "title": "Accumulate Balkrishna Industries; target of Rs 2290: KR Choksey", "description": "KR Choksey recommended\u00c2\u00a0accumulate rating on Balkrishna Industries with a target price of Rs 2290 in its research report dated May 17, 2022.", "url": "https://www.moneycontrol.com/news/business/stocks/accumulate-balkrishna-industries-target-of-rs-2290-kr-choksey-2-8523201.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2020/06/accumulate2-770x433.jpg", "publishedAt": "2022-05-17T13:57:07Z", "content": "KR Choksey's research report on Balkrishna Industries\r\nRevenue exceeded estimates for Q4FY22 due to higher volumes at 77,119 Mt (+13.4% YoY). Revenue for Q4FY22 stood at INR 23,742 Mn (+35.4% YoY). F\u2026 [+1283 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "PTI", "title": "Gold jumps Rs 388; silver rallies Rs 1,046", "description": "In the international market, gold was trading higher at USD 1,825 per ounce and silver was marginally lower at USD 20.96 per ounce.", "url": "https://www.moneycontrol.com/news/business/gold-jumps-rs-388-silver-rallies-rs-1046-8525561.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2018/02/gold_silver_bars-770x433.png", "publishedAt": "2022-05-17T13:27:54Z", "content": "Gold price in the national capital on Tuesday jumped Rs 388 to Rs 50,282 per 10 gram, reflecting rally in international precious metal prices, according to HDFC Securities . In the previous trade, th\u2026 [+645 chars]"}, {"source": {"id": null, "name": "Moneycontrol"}, "author": "Sumi Sukanya Dutta", "title": "In Depth | Rajasthan shows the way with first Right to Health draft bill; may have lessons for the country", "description": "The bill is aimed at achieving guaranteed access to quality healthcare for all citizens without catastrophic out-of-pocket expenditure", "url": "https://www.moneycontrol.com/news/trends/in-depth-rajasthan-shows-the-way-with-first-right-to-health-draft-bill-may-have-lessons-for-the-country-8524421.html", "urlToImage": "https://images.moneycontrol.com/static-mcnews/2021/11/hospital-jawaharlala-nehru-medical-collge-and-hospital-in-bhagalpur-bihar-770x433.jpg", "publishedAt": "2022-05-17T12:59:47Z", "content": "A Right to Health bill at the central level may still be in the works, but a draft bill in Rajasthan that proposes to hold the government accountable for providing affordable and easily accessible he\u2026 [+8165 chars]"}]}